Exploring Drugs and Vaccines Associated with Altered Risks and Severity of COVID-19: A UK Biobank Cohort Study of All ATC Level-4 Drug Categories Reveals Repositioning Opportunities

• 主要な著者: Yong Xiang (著者), Kenneth Chi-Yin Wong (著者), Hon-Cheong So (著者)
• フォーマット: 図書
• 出版事項: MDPI AG, 2021-09-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Effective therapies for COVID-19 are still lacking, and drug repositioning is a promising approach to address this problem. Here, we adopted a medical informatics approach to repositioning. We leveraged a large prospective cohort, the UK-Biobank (UKBB, <i>N</i> ~ 397,000), and studied as...